Drugs / RBV
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01753570 | Dec 2012 → Oct 2015 | chronic hepatitis C virus infection | Tanabe Pharma Corporation | Completed | Met primary |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RBV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01753570 ↗ |